UGTs significantly influence the pharmacokinetics of drugs. Variations in UGT activity can lead to differences in drug efficacy and toxicity. For example, genetic polymorphisms in UGT enzymes can result in altered drug metabolism rates, leading to either drug accumulation and toxicity or rapid clearance and reduced therapeutic efficacy.
